




New Jersey law protects lawful off-duty marijuana use. In 2026, the main question is where employee protections end and employer authority begins. Legal off-duty marijuana use doesn’t prevent workplace discipline when a drug-free policy falls within a recognized exception under New Jersey law.
Workers' protections and employers' responsibilities exist alongside one another. Our team at Brandon J. Broderick regularly reviews claims involving positive drug tests, workplace investigations, safety-sensitive jobs, and policies that do not always fit one category. Workers received important protections for using marijuana outside of work. But employers have the authority to address impairment, workplace safety, federal rules, and regulated industries.
This article explains where employer drug-free policies are enforceable, which exceptions continue to protect employers, and when to consult an employment lawyer in New Jersey.
New Jersey legalized recreational cannabis in February 2021. The law is called the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act, or CREAMMA. It's built on some of the strongest workplace protections in the country for off-duty cannabis users.
An employer in New Jersey can't take adverse action against a worker because the worker uses cannabis lawfully off the job. The same rule applies if the worker tests positive for cannabinoid metabolites from that off-duty use. Both current employees and job applicants are covered. Under N.J.S.A. 24:6I-52(a)(1), an employer also isn't allowed to refuse to hire someone over cannabis use.
The Cannabis Regulatory Commission issued guidance on September 9, 2022, and spelled out the central rule. A drug test isn't enough to support discipline or termination. Cannabis metabolites stay in the body for days or weeks after use and linger long after any effects have worn off. A positive result doesn't prove impairment at work.
CREAMMA doesn't cover:
Employers still have the right to test for cannabis. Reasonable suspicion of use during work or observable signs of intoxication are valid grounds. Random drug testing is also permitted, but only to determine use during prescribed work hours. The distinction is important. CREAMMA applies to what happens on the job, not what the worker did over the weekend.
Medical patients have protections that go beyond those available to recreational users. Those protections come from the Jake Honig Compassionate Use Medical Cannabis Act and the New Jersey Law Against Discrimination (NJLAD).
Similar to employees who take prescription medications, registered medical cannabis patients aren’t supposed to face automatic discipline based solely on their treatment. Employers who skip the accommodation process and move straight to termination risk violating disability rights. In just 2024, the EEOC reported 88,531 new charges of discrimination.
“The decision to speak up is powerful. But knowing what happens after — and how to protect yourself — is just as critical.”
— Olivia Rhye
On January 13, 2026, New Jersey approved P.L.2025, c.325. The law amended CREAMMA in several ways. The core protections under the law stayed the same. The amendment addressed provisions that had been causing problems for both employers and workers since 2021. The biggest target was how workplace impairment gets evaluated.
Much of the uncertainty centered on the WIRE, or Workplace Impairment Recognition Expert.
Under the original CREAMMA, an employer couldn't rely on a drug test unless a certified WIRE first conducted a physical evaluation of the employee. The Cannabis Regulatory Commission was supposed to develop the certification standards in partnership with the New Jersey State Police. Those standards never came.
Throughout 2024 and 2025, employers kept asking the CRC at public meetings when WIRE certification would actually be available. The answer was consistently that it remained in development. The CRC's guidance temporarily waived the physical evaluation requirement. Employers didn't need to use a certified WIRE while the standards were unfinished.
P.L.2025, c.325 restructured the process. The CRC will now work with the New Jersey Department of Labor and Workforce Development to create the certification standards. The role is also being renamed from Workplace Impairment Recognition Expert to Workplace Impairment Recognition Evaluator. The certification process will set minimum curriculum standards for the third-party organizations that train these evaluators.
The amendment doesn't move the bar on what counts as impairment. It clarifies who has authority over certification and how training providers get approved. Until standards are formally adopted, employers continue to rely on existing protocols. That means documented reasonable suspicion from supervisors, observable signs of impairment, performance incidents, and post-accident testing.
For public sector employees, Garrity rights factor into these investigations. Statements compelled under threat of job loss cannot be used against the worker in a criminal case. This applies even when the underlying issue involves suspected impairment or a failed drug test.
A few things changed specifically for cannabis-industry employers. Dispensaries, processors, and other licensed businesses have new background check rules to follow. The law also tightened the definition of which substances qualify as “intoxicating” for impairment purposes. From what our attorneys at Brandon J. Broderick see, employers outside the industry tend to view the amendment as a clarification rather than a substantive shift in their obligations.


Drug-free workplace policies are still allowed after the CREAMMA passed. Areas where employer authority remains intact include:
The DOT carve-out under 49 C.F.R. Part 40 covers CDL drivers, pilots, train operators, and pipeline workers. Federal regulations require drug testing for safety-sensitive transportation jobs, and federal law preempts CREAMMA in that space.
A CDL driver who tests positive for cannabis has to be removed from safety-sensitive duties under 49 CFR § 40.305, regardless of what the driver did off the clock. New Jersey's off-duty protections don't override the federal requirement. Federal contractors under the Drug-Free Workplace Act face a similar obligation. They have to maintain a drug-free workplace as a condition of holding the contract.
Federal rules apply across industries, but unequal enforcement is common. Bias in safety regulations can have real consequences for who keeps their job.
Reasonable suspicion testing remains valid. A supervisor who documents specific behavioral signs has grounds to order a drug test. Common signs include:
A positive result paired with that documentation supports discipline. The test alone isn't enough, but the combination of impairment evidence and lab results is.
Post-accident testing applies the same logic. If a workplace accident reasonably suggests impairment played a role, testing the worker is permitted. In our experience, a positive result combined with the circumstances of the incident gives the employer grounds to act.
Zero-tolerance policies aren’t illegal in New Jersey. Employers still retain the right to prohibit possession and impairment. The legal issue turns on why the employee was disciplined and whether the employer relied only on a positive test result. Policies drafted before 2021 need updating to match how the law treats cannabis differently from other controlled substances.
Two recent decisions shape how CREAMMA gets enforced. The first came from the federal appeals court in December 2024. The second came from a New Jersey appellate panel in May 2026. Together, they outline both the strength and the limits of off-duty cannabis protections.
The first decision was Zanetich v. Wal-Mart Stores East, Inc. The Third Circuit held that CREAMMA doesn’t create a private right of action for employment discrimination.
Erick Zanetich had applied for a job at a Wal-Mart facility in Swedesboro, New Jersey. Wal-Mart offered him the position conditioned on a drug test, then rescinded the offer after he tested positive for cannabis. Zanetich sued under CREAMMA and under New Jersey's public policy exception to at-will employment. The Third Circuit affirmed dismissal of both claims.
The reasoning was technical but consequential. CREAMMA prohibits the conduct Wal-Mart engaged in, but the statute doesn't expressly give workers or applicants the right to sue in court to enforce that prohibition. Without a private right of action, the enforcement path runs through the Cannabis Regulatory Commission and administrative channels. Workers who suffer discrimination still have remedies, but those remedies don't include a direct CREAMMA lawsuit for damages.
The second decision came in May 2026. Officers Omar Polanco and Norhan Mansour had been removed from their positions with the Jersey City Police Department after random drug tests in September 2022. Both officers admitted using regulated cannabis off duty, and neither was accused of using it on the job or being under the influence while working. Both were fired in March 2023.
Jersey City argued that federal law preempted CREAMMA in their case. The department argued that federal law prohibits cannabis users from possessing firearms, which meant the officers couldn’t perform an essential part of their jobs. The Appellate Division disagreed.
The court ordered Mansour and Polanco to be reinstated with back pay, benefits, and seniority. The decision reinforced that a positive test alone, without evidence of on-duty impairment, was not enough to justify termination. The same principle applies to private employers in New Jersey.
If you are facing discipline or termination related to off-duty use, contact us today for a free consultation.

Stop wondering about your rights or if you'll be taken seriously. We treat every client with respect, urgency, and honesty. Our lawyers will listen, explain your legal options, and fight for the outcome you deserve.